January 2016 Issue Table Of Contents

From The Editor

• Do What Is Right

Feature Articles

• How Merck Balances The Business Of Corporate Social Responsibility
• From Windowless Data Room To the CEO’s Office

The Enterprisers

• Amarantus: Risen From The Ashes

Capitol Perspectives

• Enactment Of Site-of-Service Neutrality Could Open Door For 340B

Companies To Watch

• Catalyst Pharmaceuticals

Deeper Dive

• Can You Afford To Take Biopharma Innovation For Granted?

Inside The Industry

• J&J Hopes To Change The Paradigm On Compassionate Use Review
• Nano Aids Pharma In The Business Of Delivering Chemo
• Should Drug Repurposing Be A Part Of Your Strategic Plan?
• The Business Benefits Of Revisiting Abandoned Therapies
• Building An Entrepreneurial Health Sciences Ecosystem From The Ground Up
• Tax Considerations When Forming A Biotech Company

Industry Leader

• Should Your Executives Help You Recruit?
• Strategic Financing Alternatives For Later-Stage Companies

Leadership Lessons

• Stop Managing! Start Coaching To Increase Productivity And Profitability

Ask The Board

• How Should A Mentee Go About Selecting A Mentor?
• From An Investor Perspective, What Are The Big Trends For 2016?
• What Are Some Of The Most Impactful Leadership Books You’ve Read During Your Career?